Rita V. Amirana

Rita V. Amirana serves as the Head of CNS Portfolio and Senior Director of Clinical Operations at Alnylam Pharmaceuticals since May 2021, following their role as Senior Director of Global Development Strategy and Clinical Operations at Sarepta Therapeutics. With extensive experience in clinical operations and drug development, Rita has led multidisciplinary teams at organizations including Synlogic, Inc. as Senior Director and at Biogen in various leadership roles. Educational credentials include an MBA from MIT Sloan School of Management, a Master's in Clinical Investigations from Boston University School of Medicine, and a Bachelor's degree in Applied Biology from Kingston University. Additionally, Rita has contributed to academia as an instructor in clinical project management and good clinical practices at Boston University School of Medicine.